Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06576661 · ClinicalTrials.gov registry record · NA

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

A NA study of Kidney Stone and Nephrolithiasis, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06576661 is a NA study of Kidney Stone and Nephrolithiasis that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 80 participants, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06576661, a NA study of Kidney Stone and Nephrolithiasis, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate the influence of real-time intrarenal pressure measurement availability on surgeons' behavior during ureteroscopy while using the ureteroscope LithoVue Elite.

Interventions

  • DEVICE INTRARENAL PRESSURE MONITORING VISIBLE

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-01-28
Est. Completion 2025-12-01
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT06576661

The ClinicalTrials.gov registry entry for NCT06576661 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (58% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Kidney Stone appearing as the primary indexed condition, and to 1 intervention - of which INTRARENAL PRESSURE MONITORING VISIBLE is the first listed.

NCT06576661 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT06576661 about?

NCT06576661 is a clinical study titled "Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes". The goal of this study is to evaluate the influence of real-time intrarenal pressure measurement availability on surgeons' behavior during ureteroscopy while using the ureteroscope LithoVue Elite.

What is the current status of trial NCT06576661?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-01-28. Estimated completion is 2025-12-01.

What conditions does trial NCT06576661 study?

This clinical trial studies the following conditions: Kidney Stone, Nephrolithiasis.

What interventions are being tested in trial NCT06576661?

The interventions under investigation include: INTRARENAL PRESSURE MONITORING VISIBLE (DEVICE).

Who is sponsoring clinical trial NCT06576661?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06576661 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.